Clinical Trial Update: Study to Explore the Effect of Mefloquine in Participants With Progressive Multifocal Leukoencephalopathy (PML) [Phase 1, Phase 2]

View source ↗

Summary

A Biogen-sponsored Phase 1/2 trial evaluating mefloquine for Progressive Multifocal Leukoencephalopathy was terminated, with results posted in July 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Progressive Multifocal Leukoencephalopathy

Drugs mentioned

• Mefloquine (Mefloquine)

Snippet

Sponsor: Biogen | Conditions: Progressive Multifocal Leukoencephalopathy | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2014-07-31